Shares Of Lupin Gained 1 Percent In Morning On The Back Of Launch

Shares of Lupin gained 1 percent in morning on the back of launch of Doxycycline tablets in the US market.

The company has launched Doxycycline Hyclate tablets USP, 75 mg and 150 mg in the US market after receiving approval from United States Food and Drug Administration.

Lupin’s Doxycycline Hyclate Tablets USP, 75 mg and 150 mg are the AB rated generic equivalent of Aqua Pharmaceuticals, LLC’s Acticlate Tablets, 75 mg and 150 mg.

For more information Call us ✆ +91 9111-179961 or Visit Dollar Advisory